Rachel Webster

Head of Oncology & Biosimilars, Market Assessment

Dr. Rachel Webster leads the production of syndicated primary and secondary market research reports and custom analysis of a wide range of oncology indications. She also provides sales and client support, helping biopharmaceutical companies uncover strategic opportunities through data-driven insights. Rachel has more than a decade of experience in market forecasting and a broad knowledge of oncology indications and markets. She has a particular interest and expertise in immuno-oncology and received her doctorate from the University of Oxford.

arrow_forwardDownload bio

Latest news

View all news arrow_forward

Related resources

View all resources arrow_forward

Subscribe to our news

Let's stay in touch. Subscribe to our latest announcements.